Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset alzheimer's disease
Loading...
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Andrographolide, Wnt signaling, Glucose metabolism, Alzheimer’s disease, Neuroprotection